Change search criteria ↓

Search results

58 projects found matching your search criteria:

  1. 1. Design and characterisation of sealing materials of prosthetic obturator being additionally a cytostatic drug reservoir.…

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

    Call: OPUS 26, Panel: ST8

  2. 2. Three-phase drug carriers - design towards a prolonged release, development of a transport model and its verification. C…

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

    Call: PRELUDIUM BIS 4, Panel: ST8

  3. 3. Drug Design: Chirality Measures as QSAR descriptors.

    Principal investigator: Piotr Jakub Lipiński

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 3, Panel: NZ7

  4. 4. Search for novel IKK-β inhibitors in the context of diseases with neuroinflammatory origin – structure-based drug design…

    Principal investigator: Emilia Aleksandra Sługocka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 22, Panel: NZ7

  5. 5. Towards the integrated molecular modelling – machine learning (MM-ML)" computational method for supporting the design of…

    Principal investigator: prof. Tomasz Puzyn

    Uniwersytet Gdański, Wydział Chemii

    Call: SHENG 2, Panel: ST5

  6. 6. Combination of Molecular Simulation and Deep Learning for De Novo Drug Design

    Principal investigator: dr Tomasz Jakub Danel

    Uniwersytet Jagielloński, Wydział Matematyki i Informatyki

    Call: PRELUDIUM 19, Panel: ST6

  7. 7. Design, bio and diversity oriented synthesis of fused pyridin-4(1H)-ones, 4H-pyrane-4-ones and 4H-thiopyran-4-ones as po…

    Principal investigator: dr Satenik Mkrtchyan

    Centrum Badań Molekularnych i Makromolekularnych PAN

    Call: POLONEZ 2, Panel: ST5

  8. 8. Design, synthesis and analysis of electrospun materials based on biodegradable polymers as potential drug delivery syste…

    Principal investigator: Marek Wojciech Rychter

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Nanobiomedyczne

    Call: PRELUDIUM 9, Panel: ST8

  9. 9. Fentanyl opioid designer drugs: from molecular modeling to in vitro studies

    Principal investigator: prof. Joanna Sadlej

    Narodowy Instytut Leków

    Call: OPUS 6, Panel: ST4

  10. 10. Design of enzyme systems for the study of chiral drugs with the use of superparamagnetic nanoparticles as carriers for b…

    Principal investigator: dr Tomasz Siódmiak

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

    Call: PRELUDIUM 5, Panel: NZ7

  11. 11. Computer aided design and prediction of properties of drug delivery systems based on carbon nanotubes architecture

    Principal investigator: dr hab. Tomasz Pańczyk

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

    Call: SONATA BIS 2, Panel: ST4

  12. 12. Search for new "drug-like" molecules designed as adenosine receptors ligands

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: HARMONIA 2, Panel: NZ4

  13. 13. Homo- and heterometallic phosphine ruthenium and iridium complexes - design, synthesis, bioactivity and magnetic-nanofor…

    Principal investigator: Sandra Amanda Kozieł

    Uniwersytet Wrocławski, Wydział Chemii

    Call: PRELUDIUM 19, Panel: ST4

  14. 14. Novel L-asparaginases as potential therapeutic agents and antimicrobial targets: structural and functional studies of en…

    Principal investigator: prof. Mariusz Jaskólski

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 19, Panel: NZ1

  15. 15. Personalized therapy - design and verification of the optimalization and manufacturing of the modified release, orally t…

    Principal investigator: prof. Sebastian Polak

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 16, Panel: NZ7

  16. 16. Modeling of quantitative structure-metabolic stability relationships as a tool to improve design of potential novel anti…

    Principal investigator: prof. Tomasz Bączek

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 12, Panel: NZ7

  17. 17. Design and chemical synthesis of peptide-based conjugates with antimicrobial activity - a promising approach to improve …

    Principal investigator: prof. Krzysztof Rolka

    Uniwersytet Gdański, Wydział Chemii

    Call: OPUS 11, Panel: ST5

  18. 18. Design and synthesis of pH- and redox-responsive dimeric dendrons as a nanotools for transporting siRNA or drugs into gl…

    Principal investigator: prof. Zofia Lipkowska

    Instytut Chemii Organicznej Polska Akademia Nauk

    Call: OPUS 10, Panel: ST5

  19. 19. Self-learning systems in the design of compounds modulating GPCR receptors activation.

    Principal investigator: dr hab. Dorota Latek

    Uniwersytet Warszawski, Wydział Chemii

    Call: OPUS 20, Panel: NZ2

  20. 20. Stealth" asparaginases as improved protein drugs for the treatment of childhood acute lymphoblastic leukemia (ALL)

    Principal investigator: prof. Matthias Bochtler

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

    Call: OPUS 27, Panel: NZ1

  21. 21. Search for Inhibitors of Human δ1-Pyrroline-5-Carboxylate Reductase 1 (PYCR1) as Lead Molecules for the Development of N…

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 22, Panel: NZ7

  22. 22. Design and Pharmacological Evaluation of Marine Alkaloid-Inspired 5-HT2A Receptor Ligands

    Principal investigator: Szymon Kazimierz Kordylewski

    Instytut Farmakologii PAN

    Call: PRELUDIUM 24, Panel: NZ1

  23. 23. Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA BIS 13, Panel: NZ7

  24. 24. Designing Active Inhibitors of SARS-CoV-2 Methyltransferases

    Principal investigator: Alex Jun Matsuda

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: PRELUDIUM 22, Panel: NZ7

  25. 25. Design, Synthesis and Characterization of Functionalized 1,2,4-Trioxanes/Trioxepanes for Antimalarial and Anticancer Use

    Principal investigator: dr Mohit Kumar Tiwari

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: SONATINA 7, Panel: NZ7

  26. 26. Development of tools for the rational design of peptide therapeutics

    Principal investigator: prof. Sebastian Kmiecik

    Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

    Call: OPUS 20, Panel: NZ2

  27. 27. Novel approach in the search for asthma and COPD therapies - computer aided design of multi-target-directed ligands bloc…

    Principal investigator: Alicja Aleksandra Gawalska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 19, Panel: NZ7

  28. 28. Rational design and evaluation of functionally biased opioid agonists

    Principal investigator: prof. Ryszard Przewłocki

    Instytut Farmakologii PAN

    Call: OPUS 16, Panel: NZ7

  29. 29. Molecular picture of the mechanochemical coupling in ATP synthase as a conceptual framework for the development of novel…

    Principal investigator: dr hab. Jacek Czub

    Politechnika Gdańska, Wydział Chemiczny

    Call: SONATA BIS 7, Panel: NZ2

  30. 30. Novel multi-target directed ligands combining cholinesterase inhibition and 5-HT6 antagonism - design, synthesis and pha…

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 12, Panel: NZ7

  31. 31. Development of protocol for in silico design of compounds inhibit Ebola virus infection

    Principal investigator: Dawid Zdzisław Warszycki

    Instytut Farmakologii PAN

    Call: PRELUDIUM 11, Panel: NZ2

  32. 32. Computational alchemy and experimental validation: a hybrid approach for designing new antimicrobial peptides

    Principal investigator: Piotr Maciej Chyży

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: PRELUDIUM 22, Panel: NZ1

  33. 33. Structure-guided design of histone demethylase inhibitors for cancer therapy.

    Principal investigator: dr Piotr Henryk Małecki

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA 17, Panel: NZ7

  34. 34. Study of iron catalysis for the activation of carbon-hydrogen bonds: design of new reactions and their application in me…

    Principal investigator: dr Michał Szostak

    Uniwersytet Opolski, Wydział Chemii

    Call: SONATA 8, Panel: ST5

  35. 35. Design and synthesis of the porous materials based on biopolymers and their composites with magnetite as potential sorbe…

    Principal investigator: dr Anna Daria Kaczmarek-Kędziera

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

    Call: OPUS 7, Panel: ST8

  36. 36. Bioactive organoselenium compounds in self-organizing systems: design, synthesis and biological evaluation

    Principal investigator: dr Magdalena Piętka-Ottlik

    Politechnika Wrocławska, Wydział Chemiczny

    Call: SONATA 5, Panel: ST5

  37. 37. Novel DNA Minor Groove Helix Alkylating Agents - Design, Synthesis and Antitumor Activity Screening

    Principal investigator: dr Adam Józef Mieczkowski

    Instytut Biochemii i Biofizyki PAN

    Call: OPUS 1, Panel: NZ4

  38. 38. "I like to move it, move it" – molecular dynamics-driven optimization of ligand residence time as an opportunity to impr…

    Principal investigator: dr hab. Sabina Marta Podlewska

    Instytut Farmakologii PAN

    Call: OPUS 25, Panel: NZ7

  39. 39. Bis(benzosiloxaboroles) as a new class of potential antibiotics - a perspective solution to growing problem of antimicro…

    Principal investigator: Krzysztof Nowicki

    Politechnika Warszawska, Wydział Chemiczny

    Call: PRELUDIUM 22, Panel: ST5

  40. 40. Novel broad-spectrum central nervous system active substances: optimization of their multi-target profile

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: OPUS 22, Panel: NZ7

  41. 41. Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinocice…

    Principal investigator: dr Michał Andrzej Abram

    Uniwersytet Jagielloński

    Call: OPUS 29, Panel: NZ7

  42. 42. NMR Spectroscopy as Molecular Language: A Deep Learning Approach to Bioactivity Prediction

    Principal investigator: Arkadiusz Bogumił Leniak

    Instytut Farmakologii PAN

    Call: PRELUDIUM 24, Panel: NZ7

  43. 43. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t…

    Principal investigator: dr hab. Damian Nestor Plażuk

    Uniwersytet Łódzki

    Call: OPUS 27, Panel: NZ7

  44. 44. Taming aggregation with AmyloGraph 2.0: a database and prediction models of amyloid self-assembly modulators

    Principal investigator: dr Michał Jan Burdukiewicz

    Uniwersytet Medyczny w Białymstoku

    Call: SONATA 19, Panel: NZ7

  45. 45. Decrypting the "sulfation code" of glycosaminoglycans for understanding their function in the extracellular matrix

    Principal investigator: dr hab. Sergey Samsonov

    Uniwersytet Gdański, Wydział Chemii

    Call: OPUS 25, Panel: ST4

  46. 46. Targeted inhibition of hypusination pathway

    Principal investigator: dr Przemysław Marek Grudnik

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: OPUS 24, Panel: NZ7

  47. 47. Computational deciphering of pro-ferroptotic cell death protein machinery as a fundamental step in the search for therap…

    Principal investigator: dr hab. Karolina Anna Mikulska-Rumińska

    Uniwersytet Mikołaja Kopernika, Wydział Fizyki, Astronomii i Informatyki Stosowanej

    Call: SONATA BIS 12, Panel: ST4

  48. 48. Inhibiting the Mitochondrial Intermembrane Space Assembly pathway as a newapproach to prevent metabolic reprogramming of…

    Principal investigator: dr hab. Carlo Vascotto

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: OPUS 22, Panel: NZ5

  49. 49. The new methodology for better understanding of ligand-RNA interactions.

    Principal investigator: dr Filip Artur Stefaniak

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

    Call: OPUS 20, Panel: NZ2

  50. 50. Fluorine substitution – a new algorithm for increasing biological activity

    Principal investigator: Wojciech Pietruś

    Instytut Farmakologii PAN

    Call: PRELUDIUM 18, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski